Home » Topics » Regulatory

Regulatory
RSS

FDA approves SB's Kytril for prevention of radiation-induced nausea and vomiting

July 29, 1999

New thrombin inhibitor approved in Italy for antithrombotic prophylaxis

July 29, 1999

Irinotecan approved as first-line treatment for advanced colorectal cancer in Europe

July 29, 1999

FDA approves pediatric formulation of Topamax

July 28, 1999

Fujisawa initiates enrollment in phase III RA trial of Prograf

July 27, 1999

OraSolv Zomig receives first regulatory approval in Sweden for migraine

July 22, 1999

Tachykinin antagonists now proposed for attention deficit disorders

July 22, 1999

Use of zonisamide for neurodegenerative disorders

July 21, 1999

Priority review status granted to Immunex's MS drug

July 21, 1999

PDT with Photofrin cleared in Canada for certain forms of lung cancer

July 19, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.